08:00 , Jan 6, 2014 |  BC Week In Review  |  Company News

Agilis Biotherapeutics management update

Agilis Biotherapeutics LLC , Germantown, Md.   Business: Neurology, Gene/Cell therapy   Hired: George Zorich as CEO, formerly president of North American operations at Bioniche Pharma Holdings Ltd. , which Mylan Inc. acquired  ...
00:17 , Jan 1, 2014 |  BC Extra  |  Company News

Agilis announces Intrexon deal, CEO and financing

Newco Agilis Biotherapeutics LLC (Germantown, Md.) announced a deal with synthetic biology company Intrexon Corp. (NYSE:XON), named a new CEO and said it raised $8 million on Tuesday. Agilis and Intrexon partnered to develop DNA-based...
07:00 , Sep 13, 2010 |  BC Week In Review  |  Company News

Bioniche Pharma, Mylan deal

Mylan completed its previously announced acquisition of Bioniche Pharma from private equity firm RoundTable Healthcare Partners for $550 million in cash (see BioCentury, July 19). Bioniche Pharma Holdings Ltd. , Casla, Ireland   Mylan Inc....
07:00 , Jul 19, 2010 |  BC Week In Review  |  Company News

Bioniche Pharma, Mylan deal

Mylan will acquire Bioniche Pharma from private equity firm RoundTable Healthcare Partners for $550 million in cash. RoundTable acquired the injectable generics company from Bioniche Life Sciences Inc. (TSX:BNC, Belleville, Ontario) in 2006. Mylan said...
07:00 , May 28, 2007 |  BC Week In Review  |  Company News

Bioniche Pharma Group Ltd., Nabi deal

Bioniche's Bioniche Teoranta unit completed its previously announced acquisition of NABI's Aloprim IV allopurinol for $3.7 million, including $1.3 million up front, $1.4 million at year end and $1 million at the end of 2008...
07:00 , Apr 23, 2007 |  BC Week In Review  |  Company News

Bioniche Pharma Group Ltd., Nabi deal

NABI agreed to sell Aloprim IV allopurinol to Bioniche’s Bioniche Teoranta unit for $3.7 million. The move is part of NABI’s plan to reorganize into two business units and partner or sell certain of its...
08:00 , Dec 18, 2006 |  BC Week In Review  |  Company News

Bioniche deal

BNC completed the previously announced sale of its 10% stake in former subsidiary Bioniche Pharma Group Ltd. to an undisclosed company for $6 million in cash. The deal also includes BNC's royalty interest in osteoarthritis...
08:00 , Nov 13, 2006 |  BC Week In Review  |  Company News

Bioniche deal

BNC will sell its 10% stake in former subsidiary Bioniche Pharma Group Ltd. to an undisclosed company for $6 million in cash. The deal includes BNC's royalty interest in osteoarthritis product Suplasyn sodium hyaluronate solution,...
07:00 , May 29, 2006 |  BC Week In Review  |  Company News

Edwards, RoundTable Healthcare Partners deal

EW sold its RIMSO-50 dimethyl sulfoxide and Cryoserv dimethyl sulfoxide solutions to Bioniche Pharma Group Ltd. (County Galway, Ireland) for an undisclosed price. RIMSO-50 is marketed in the U.S. and Canada for interstitial cystitis, while...
07:00 , May 8, 2006 |  BC Week In Review  |  Company News

Bioniche, RoundTable Health Partners deal

BNC sold its Cystistat sodium hyaluronate solution to former subsidiary Bioniche Pharma Group Ltd. (County Galway, Ireland) for C$10 million ($8.2 million) in cash. Cystistat is marketed in the EU, Canada and other countries for...